Inhibition of PDE2A, but not PDE9A, modulates presynaptic short‐term plasticity measured by paired‐pulse facilitation in the CA1 region of the hippocampus
Abstract
Phosphodiesterase (PDE) inhibitors are currently considered promising therapeutic targets for treatment of cognitive impairment in diseases such as Schizophrenia and Alzheimer's disease. Inhibitors of PDE2A and PDE9A have emerged as potential candidates shown to improve synaptic plasticity and memory function in animals. However, the functional relevance of their putative different localization in the neuron is not understood. Thus, this study aims at elucidating potential presynaptic effects of PDE2A inhibition in comparison to the inhibition of PDE9A. For this purpose, we used paired‐pulse facilitation (PPF), a model of short‐term synaptic plasticity related to presynaptic function. First, we performed a series of experiments to validate the model in acute rat hippocampal slices using several reference substances including calcium channel blockers, glutamatergic receptor antagonists, and GPCR agonists. Second, we analysed the effect of PDE2A and PDE9A inhibition and their role regulating the influence that the second messengers cAMP and cGMP exert on basal transmission. Our results show that the interplay between the adenylyl cyclase activator forskolin, the soluble guanylyl cyclase activator BAY 41‐8543 and the PDE2A inhibitor PF‐999 reveals a primarily presynaptic mechanism of action of PDE2A inhibition. On the contrary, inhibition of PDE9A did not alter PPF under similar conditions. In conclusion, these data provide new evidence supporting a role of PDE2A modulating short‐term synaptic plasticity. Moreover, this function of PDE2A is suggested to rely on an active modulation of the cAMP hydrolysis as a response to changes in cGMP levels at the presynaptic level. Synapse 69:484–496, 2015.Keywords
This publication has 62 references indexed in Scilit:
- Phosphodiesterases in neurodegenerative disordersIUBMB Life, 2012
- Natriuretic peptides block synaptic transmission by activating phosphodiesterase 2A and reducing presynaptic PKA activityProceedings of the National Academy of Sciences, 2012
- Short-Term Presynaptic PlasticityCold Spring Harbor Perspectives in Biology, 2012
- Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In VivoThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTPNeuropharmacology, 2012
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissuesNeuropharmacology, 2010
- Nitric oxide signaling via cGMP‐stimulated phosphodiesterase in striatal neuronsSynapse, 2010
- Dual Acylation of PDE2A Splice Variant 3Journal of Biological Chemistry, 2009
- Selective phosphodiesterase inhibitors: a promising target for cognition enhancementPsychopharmacology, 2008
- Multimodal gain control at the hippocampal Schaffer collateral-CA1 synapseNeuroscience Letters, 2007